FindTrial
Sign In

To study the effectiveness of tranexamic acid in reducing blood loss and postoperative complications in patients undergoing breast surgery

Study of efficacy of tranexamic acid in reducing blood loss and postoperative complications in breast surgery - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065861
Enrollment
60
Registered
2024-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D249- Benign neoplasm of unspecified breast Health Condition 2: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Tranaxemic acid: 1 g Intravenous tranexamic acid preoperative and 3 doses in the 1st 24 hrs postoperative period Control Intervention1: N/A: N/A

Sponsors

Dr Hariharan R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All females above 18 yrs of age undergoing breast surgery who consent to the study

Exclusion criteria

Exclusion criteria: Patients not giving consent Patients with uncontrolled comorbidities History of prior thromboembolic events Patients with severe renal impairment Patients with seizure disorder Patients with retinal vein occlusion

Design outcomes

Primary

MeasureTime frame
1. Effect of tranexamic acid in reducing postoperative bleeding 2 effect of tranexamic acid in reducing postoperative pain 3 effect of tranexamic acid in reducing other postoperative complicationsTimepoint: 4 weeks—

Secondary

MeasureTime frame
1 Effect of tranexamic acid in reducing other postoperative complicationsTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactHariharan R

Govt Stanley medical college

drbspriya@yahoo.co.in94444086644

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026